CPRX
Catalyst Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$3.44B
P/E Ratio
16.74
EPS
$1.68
Beta
0.66
52W High
$32.56
52W Low
$19.05
50-Day MA
$24.90
200-Day MA
$22.67
Dividend Yield
—
Profit Margin
36.40%
Forward P/E
11.63
PEG Ratio
0.00
About Catalyst Pharmaceuticals Inc
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, neuromuscular, and chronic neurological diseases in the United States. The company is headquartered in Coral Gables, Florida.
Fundamentals
| Revenue (TTM) | $588.99M |
| Gross Profit (TTM) | $489.03M |
| EBITDA | $295.65M |
| Operating Margin | 40.50% |
| Return on Equity | 25.50% |
| Return on Assets | 16.50% |
| Revenue/Share (TTM) | $4.82 |
| Book Value | $7.79 |
| Price-to-Book | 3.62 |
| Price-to-Sales (TTM) | 5.83 |
| EV/Revenue | 4.66 |
| EV/EBITDA | 9.28 |
| Quarterly Earnings Growth (YoY) | -6.40% |
| Quarterly Revenue Growth (YoY) | 7.60% |
| Shares Outstanding | $122.12M |
| Float | $114.53M |
| % Insiders | 6.18% |
| % Institutions | 89.15% |
Historical Volatility
HV 10-Day
54.36%
HV 20-Day
41.70%
HV 30-Day
40.02%
HV 60-Day
39.31%
HV Rank
81.7%
Volatility is currently expanding
Analyst Ratings
Consensus ($34.00 target)
7
BuyData last updated: 5/1/2026